Constitutive Somatostatin Receptor Subtype-3 Signaling Suppresses Growth Hormone Synthesis
Authors:
Open Access
- 1 April 2014
- journal article
- other
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 28 (4) , 554-564
Abstract
Somatostatin signals through somatostatin receptor subtypes (SSTR) 2 and 5 to attenuate GH secretion. Although expressed in normal pituitary glands and in GH-secreting pituitary tumors, SSTR3 function was unclear, and we have now determined the role of SSTR3 in somatotroph function. Stable rat pituitary tumor cell (GC) transfectants of human SSTR3 (GpSSTR3WT) showed suppression of rat (r) GH promoter activity, GH mRNA expression, and secreted GH concordant with suppressed cAMP/protein kinase A (PKA) signaling. In contrast, cAMP levels and GH expression were unchanged in cells expressing a mutant SSTR3 DRY motif (GpSSTR3R141A). GH expression was rescued by treatment of GpSSTR3WT with forskolin and 8-bromo-cAMP. GpSSTR3WT exhibited activation of glycogen synthase kinase3-β (GSK3-β), a PKA substrate, which was also reversed by 8-Bromo-cAMP treatment. Moreover, SSTR3-dependent GH transcriptional inhibition was rescued by inhibition of GSK3-β. GpSSTR3WT exhibited elevated Pit-1 serine phosphorylation and decreased Pit-1 occupancy of the rGH promoter with sustained Pit-1 expression. GSK3-β and Pit-1 physically interacted with each other, indicating that Pit-1 may be a GSK3-β phosphorylation substrate. In conclusion, constitutive SSTR3 activity mediates transcriptional repression of GH through cAMP/PKA, leading to subsequent activation of GSK3-β and increased Pit-1 phosphorylation and ultimately attenuating Pit-1 binding to the rGH promoter.Keywords
This publication has 47 references indexed in Scilit:
- Coexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosisJournal of Molecular Signaling, 2012
- GSK-3: Functional Insights from Cell Biology and Animal ModelsFrontiers in Molecular Neuroscience, 2011
- CRH and SRIF Have Opposite Effects on the Wnt/β-Catenin Signalling Pathway Through PKA/GSK-3β in Corticotroph Pituitary CellsCancer Investigation, 2010
- GSK3: a multifaceted kinase in Wnt signalingTrends in Biochemical Sciences, 2010
- Pituitary somatostatin receptor signalingTrends in Endocrinology & Metabolism, 2010
- A Pit-1 Threonine 220 Phosphomimic Reduces Binding to Monomeric DNA Sites to Inhibit Ras and Estrogen Stimulation of the Prolactin Gene PromoterMolecular Endocrinology, 2010
- Acromegaly pathogenesis and treatmentJournal of Clinical Investigation, 2009
- Null mutant mouse models of somatostatin and cortistatin, and their receptorsMolecular and Cellular Endocrinology, 2008
- Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancerNature Reviews Drug Discovery, 2007
- Control of growth hormone synthesisDomestic Animal Endocrinology, 1996